Dr. Sarah Camargos is joined by Dr. Rajeev Kumar to explore early research on targeting neuroinflammation in Huntington's disease. Dr. Kumar delves into the intricacies of the complement cascade, highlighting the pivotal role of C1q as the recognition molecule at the top of this immune system chain reaction and how ANX005 aims to prevent the initiation of the cascade. He further discusses the implications of biomarker advancements and safety protocols in moving towards more effective treatments for Huntington's disease.
Podden och tillhörande omslagsbild på den här sidan tillhör
International Parkinson and Movement Disorder Society. Innehållet i podden är skapat av International Parkinson and Movement Disorder Society och inte av,
eller tillsammans med, Poddtoppen.